Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques
Pierre Amarenco, Stephen Davis, Elizabeth F Jones, Ariel A Cohen, Wolf-Dieter Heiss, Markku Kaste, Cedric Laouenan, Dennis Young, Malcolm Macleod, Geoffrey A Donnan
Stroke | LIPPINCOTT WILLIAMS & WILKINS | Published : 2014
Awarded by French government
This trial was supported by a research grant from the French government (Programme Hospitalier de Recherche Clinique: AOM-97211/P991205; Eudract: 2007-003644-30) and the Departement a la Recherche Clinique et au Developpement, Assistance Publique-Hopitaux de Paris, the Australian National Health and Medical Research Council, and supported by SOS-Attaque Cerebrale association. Sanofi and Bristol-Myers Squibb provided study drugs free of charge. Sanofi Australia provided a small, unrestricted arms-length grant to Aortic Arch Related Cerebral Hazard-Australia team. The investigators were fully responsible for the protocol design, conduct of the study, data collection, monitoring, data management, analysis and interpretation of the data, and writing of the article, without any pharmaceutical company involvement.